Securities code: 000972 securities abbreviation: * ST Zhongji Announcement No.: 2022-004
Chalkis Health Industry Co.Ltd(000972)
Risk warning announcement on the possible delisting of the company’s shares
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
According to article 9.3.5 of the Listing Rules of Shenzhen Stock Exchange (revised 2022), “listed companies due to the occurrence of items (I) to (III) of paragraph 1 of article 9.3.1 of these rules” Under the circumstances of item, if the delisting risk warning is implemented for its stock trading, it shall disclose the risk warning announcement that the stock may be delisted within one month after the end of the accounting year of the year in which the delisting risk warning is implemented for its stock trading, and disclose the risk warning announcement at least twice before disclosing the annual report of the year, Please pay attention to investment risks.
1、 About the delisting risk warning and other risk warnings implemented in the company’s stock trading
Chalkis Health Industry Co.Ltd(000972) (hereinafter referred to as “the company”) has a negative net profit before and after deducting non recurring profits and losses in 2020, and the annual operating income is less than 100 million yuan. According to the relevant provisions of the Listing Rules of Shenzhen Stock Exchange, Shenzhen Stock Exchange implements “delisting risk warning” for the company’s stock trading; The net profit of the company before and after deducting non recurring profits and losses in the last three years, whichever is lower, is negative, and the 2020 audit report shows that there is uncertainty in the company’s sustainable operation ability. According to the relevant provisions of the stock listing rules of Shenzhen Stock Exchange, Shenzhen Stock Exchange implements “other risk warning” for the company’s stock trading.
2、 Possible delisting situations of the company
According to the provisions of the Listing Rules of Shenzhen Stock Exchange (revised in 2022): after the delisting risk warning is implemented for the stock trading of a listed company due to the circumstances in items (I) to (III) of paragraph 1 of article 9.3.1 of these rules, one of the following circumstances occurs in the first accounting year, Shenzhen stock exchange decides to terminate the listing and trading of its shares: (I) the audited net profit is negative and the operating income is less than 100 million yuan, or the net profit of the most recent fiscal year is negative and the operating income is less than 100 million yuan after retroactive restatement; (II) the audited ending net assets are negative, or the ending net assets of the latest fiscal year after retroactive restatement are negative; (III) the financial accounting report is issued with qualified opinions, unable to express opinions or negative opinions; (IV) failing to disclose the annual report guaranteed by more than half of the directors to be true, accurate and complete within the statutory time limit; (V) although it complies with the provisions of article 9.3.7, it fails to apply to the exchange for cancellation of delisting risk warning within the specified time limit; (VI) due to non-compliance with article 9.3.7, the delisting risk warning application was not reviewed and approved by the exchange.
The company’s retroactive restatement leads to the occurrence of items (I) and (II) of paragraph 1 of article 9.3.1 of these rules, or after its stock trading is warned of delisting risk due to the occurrence of item (IV) of paragraph 1 of article 9.3.1, In case of any of the circumstances in items (IV) to (VI) of the preceding paragraph or the circumstances in items (I) to (III) of the preceding paragraph occur in the year next to the corresponding year of the delisting risk warning index, the Shenzhen Stock Exchange shall decide to terminate the listing and trading of its shares.
If one of the above circumstances occurs in 2021, the listing of the company’s shares will be terminated. According to the preliminary calculation of the company’s financial department, the operating income in 2021 is expected to be about 150 million yuan to 190 million yuan, and the operating income after deducting the business income irrelevant to the main business and the income without commercial substance is about 142 million yuan to 182 million yuan; The net profit loss attributable to the shareholders of the listed company ranges from 120 million yuan to 80 million yuan, and the net profit loss after deducting non recurring profits and losses ranges from 115 million yuan to 75 million yuan.
For details, please refer to the 2021 annual performance forecast (Announcement No.: 2022-001) disclosed by the company on the designated information disclosure media on January 21, 2022.
3、 Other tips
1. As of the disclosure date of this announcement, the audit of the company’s 2021 annual report is still in progress, and the final financial data of 2021 shall be subject to the audited 2021 annual report disclosed by the company. The company will disclose the risk warning announcement at least once before the disclosure of the 2021 annual report.
2. The scheduled disclosure date of the company’s 2021 annual report is February 26, 2022. The information disclosure media designated by the company are securities times, securities daily and http://www.cn.info.com.cn, All information of the company is subject to the information published in the above designated media. Investors are invited to invest rationally and pay attention to risks.
It is hereby announced.
Chalkis Health Industry Co.Ltd(000972) board of directors February 14, 2022
